Three Phase 3 Trials of Datopotamab Deruxtecan-Based Combinations Initiated in Patients With Advanced Nonsquamous Non-Small Cell Lung Cancer
在愛文思控股非鱗狀非小細胞肺癌患者中啓動了基於Datopotamab Deruxtecan的三期臨床試驗組合
Three Phase 3 Trials of Datopotamab Deruxtecan-Based Combinations Initiated in Patients With Advanced Nonsquamous Non-Small Cell Lung Cancer
在愛文思控股非鱗狀非小細胞肺癌患者中啓動了基於Datopotamab Deruxtecan的三期臨床試驗組合
譯文內容由第三人軟體翻譯。